Metformin and Abdominal Aortic Aneurysm

European Journal of Vascular and Endovascular Surgery

Volumn 54, Issue 6, 2017, Pages 679-680

  Hinchliffe, Robert J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

ABDOMINAL AORTIC ANEURYSM; DISEASE COURSE; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SCREENING; TAIWAN; UNITED KINGDOM;

AORTIC ANEURYSM, ABDOMINAL; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN;

EID: 85030653235     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2017.08.016     Document Type: Editorial

References (13)

1. Thompson, A., Cooper, J.A., Fabricius, M., Humphries, S.E., Ashton, H.A., Hafez, H., An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J Vasc Surg 52 (2010), 55–61.
2. Oliver-Williams, C., Sweeting, M., Turton, G., Parkin, D., Cooper, D., Rodd, C., et al. Lessons learned about prevalence and growth rates of abdominal aortic aneurysms from a 25-year ultrasound population screening programme. Br J Surg, 2017 [in press].
3. IMPROVE trial investigators, Powell, J.T., Hinchliffe, R.J., Thompson, M.M., Sweeting, M.J., Ashleigh, R., Bell, R., et al. Observations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm. Br J Surg 101 (2014), 216–224.
4. Freiberg, M.S., Arnold, A.M., Newman, A.B., Edwards, M.S., Kraemer, K.L., Kuller, L.H., Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events. Circulation 117 (2008), 1010–1017.
5. De Rango, P., Farchioni, L., Fiorucci, B., Lenti, M., Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 47 (2014), 243–261.
6. Miyama, N., Dua, M.M., Yeung, J.J., Schultz, G.M., Asagami, T., Sho, E., et al. Hyperglycemia limits experimental aortic aneurysm progression. J Vasc Surg 52 (2010), 975–983.
7. De Rango, P., Cao, P., Cieri, E., Parlani, G., Lenti, M., Simonte, G., et al., Comparison of surveillance vs. Aortic Endografting for Small Aneurysm Repair (CAESAR) investigators group. Effects of diabetes on small aortic aneurysms under surveillance according to a subgroup analysis from a randomized trial. J Vasc Surg 56 (2012), 1555–1563.
8. Isoda, K., Young, J.L., Zirlik, A., MacFarlane, L.A., Tsuboi, N., Gerdes, N., et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol 26 (2006), 611–617.
9. Jones, A., Deb, R., Torsney, E., Howe, F., Dunkley, M., Gnaneswaran, Y., et al. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms. Circulation 119 (2009), 3125–3132.
10. Hsu, C.Y., Su, Y.W., Chen, Y.T., Tsai, S.H., Chang, C.C., Li, S.Y., et al. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis. Cardiovasc Diabetol, 15, 2016, 125.
11. Golledge, J., Moxon, J., Pinchbeck, J., Anderson, G., Rowbotham, S., Jenkins, J., et al. Association between metformin prescription and growth rates of abdominal aortic aneurysms. Br J Surg 104 (2017), 1486–1493.
12. Fujimura, N., Xiong, J., Kettler, E.B., Xuan, H., Glover, K.J., Mell, M.W., et al. Metformin treatment status and abdominal aortic aneurysm disease progression. J Vasc Surg 64 (2016), 46–54.
13. Kristensen, K.L., Pottegård, A., Hallas, J., Rasmussen, L.M., Lindholt, J.S., Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms. J Vasc Surg 66 (2017), 768–774.